EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Global Seroprevalence (HSV‐2 IgG), Risk Factors, and Outcomes of Genital Herpes Infection During Pregnancy: A Systematic Review and Meta‐Analysis

Nader Salari, Ashkan Fatemi Gohar, Fateme Lotfi, Farnaz Jalili, Negar Heidari, Paria Heidari, Masoud Mohammadi iD

Journal of Pregnancy · 2026-01 · 2026 (1)

DOI: 10.1155/jp/7595836 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Pregnancy, online erschienen am 25.04.2026. Verfasst von Nader Salari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran, kums.ac.ir. Hauptthemen laut MEDLINE: Herpes Genitalis, Herpesvirus 2, Human, Pregnancy Complications, Infectious. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputy for Research and Technology, Kermanshah University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genital herpes (Herpes Simplex Virus Type 2) infection (HSV‐2 IgG) is a common infection in adults. Given that the virus can indirectly affect fetal development, the infection is particularly important in pregnant women. The disease can remain latent for extended periods and, in addition to causing chronic and recurrent complications, can sometimes result in miscarriage. This study is aimed at investigating the global seroprevalence, risk factors, and outcomes of HSV‐2 IgG during pregnancy through a systematic review and meta‐analysis.

Method

In this study, the electronic databases, including PubMed, Scopus, Web of Science, Embase, ScienceDirect, and Google Scholar, were systematically searched to find studies reporting the seroprevalence of HSV‐2 IgG until February 2025. A random‐effects model was used for analysis. Heterogeneity between studies was assessed using the I 2 index. Data analysis was performed using the software Comprehensive Meta‐Analysis (Version 2).

Results

In the analysis of 15 studies with a sample size of 19,197 pregnant women, the global seroprevalence of HSV‐2 IgG in pregnant women was reported as 23.4%. In examining the factors influencing the heterogeneity of the studies and the impact of sample size on this heterogeneity, it was reported that as sample size increased, the seroprevalence of HSV‐2 IgG in pregnant women decreased ( p < 0.05). Additionally, the findings suggested that with the increase in the year of study, the seroprevalence decreased ( p < 0.05). In this study, a history of sexually transmitted diseases and having more than one sexual partner were also identified as factors associated with HSV‐2 IgG in pregnancy.

Conclusion

Given the seroprevalence (HSV‐2 IgG), associated factors, and significant complications of contracting this infection during pregnancy, it is recommended that relevant authorities provide the necessary resources to increase awareness among the public and apply appropriate prevention and follow‐up measures to minimize the risk of infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes GenitalisHerpesvirus 2, HumanPregnancy Complications, InfectiousHumansFemalePregnancySeroepidemiologic StudiesRisk FactorsImmunoglobulin GAntibodies, Viral

Stichwörter der Autor:innen

HSV-2 IgGHerpes Simplex Virus Type 2pregnancy seroprevalence

Substanzen

Immunoglobulin GAntibodies, Viral

Autor:innen und Institutionen

  • Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran, kums.ac.ir.
  • Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran, kums.ac.ir.
  • Department of Medicine, School of Medicine, University of Adelaide, Adelaide, Australia, adelaide.edu.au.
  • Department of Health Education and Promotion, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran, kums.ac.ir.
  • Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran, jums.ac.ir.

ORCID-Profile: Masoud Mohammadi

Förderung

  • Deputy for Research and Technology, Kermanshah University of Medical Sciences

Zitieren

APA

Salari, N., Gohar, A. F., Lotfi, F., Jalili, F., Heidari, N., Heidari, P., & Mohammadi, M. (2026). Global Seroprevalence (HSV‐2 IgG), Risk Factors, and Outcomes of Genital Herpes Infection During Pregnancy: A Systematic Review and Meta‐Analysis. Journal of Pregnancy, 2026(1). https://doi.org/10.1155/jp/7595836

Vancouver

Salari N, Gohar AF, Lotfi F, Jalili F, Heidari N, Heidari P, et al. Global Seroprevalence (HSV‐2 IgG), Risk Factors, and Outcomes of Genital Herpes Infection During Pregnancy: A Systematic Review and Meta‐Analysis. Journal of Pregnancy. 2026;2026(1). doi:10.1155/jp/7595836

BibTeX
@article{Salari2026,
  author = {Salari, Nader and Gohar, Ashkan Fatemi and Lotfi, Fateme and Jalili, Farnaz and Heidari, Negar and Heidari, Paria and Mohammadi, Masoud},
  title = {Global Seroprevalence (HSV‐2 IgG), Risk Factors, and Outcomes of Genital Herpes Infection During Pregnancy: A Systematic Review and Meta‐Analysis},
  journal = {Journal of Pregnancy},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jp/7595836}
}
Kostenlos starten →